Search results for "regression"

showing 10 items of 2619 documents

New balloon catheter for prolonged percutaneous transluminal coronary angioplasty and bypass flow in occluded vessels.

1986

A new balloon catheter was developed for continuous perfusion of coronary arteries during angioplasty (CPC catheter). Steerable Gruntzig balloon catheters (3.7 mm) with two lumina were formed. The first lumen was used for balloon inflation. Side holes to the second lumen proximally and distally to the balloon were created for coronary perfusion even during inflation phase. At a perfusion pressure of 120 mmHg, a flow rate of 63 +/- 3 ml/min with 0.9% saline and 43 +/- 1 ml/min with plasma expander were measured. In experiments on five dogs, dilation time until appearance of signs of ischemia could be prolonged in three of five dogs from 30 to 40 s, 120 to 203 s, and 180 to 420 s comparing co…

AdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentLumen (anatomy)Arterial Occlusive DiseasesCoronary DiseaseBalloonAnginaDogsAngioplastyInternal medicineMedicineAnimalsHumansbusiness.industryBalloon catheterMiddle Agedmedicine.diseaseSurgeryCoronary arteriesPerfusionCathetermedicine.anatomical_structureCoronary vesselCardiologyRegression AnalysisCardiology and Cardiovascular MedicinebusinessAngioplasty BalloonCatheterization and cardiovascular diagnosis
researchProduct

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated don…

2009

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Anti-T-cell globulins (ATGs) might lower the incidence of GVHD. We did a prospective, randomised, multicentre, open-label, phase 3 trial to compare standard GVHD prophylaxis with ciclosporin and methotrexate with or without anti-Jurkat ATG-Fresenius (ATG-F).Between May 26, 2003, and Feb 8, 2007, 202 patients with haematological malignancies were centrally randomly assigned using computer-generated centre-stratified block randomisation between treatment groups receiving ciclosporin and methotrexate with or without additional ATG-F. One patie…

AdultMalemedicine.medical_specialtyTransplantation ConditioningAdolescentmedicine.medical_treatmentT-LymphocytesGraft vs Host DiseaseHematopoietic stem cell transplantationGastroenterologyInternal medicinemedicineHumansTransplantation HomologousCumulative incidenceProspective StudiesAntilymphocyte Serumbusiness.industryHazard ratioHematopoietic Stem Cell TransplantationMiddle AgedCiclosporinmedicine.diseaseSurvival AnalysisAnti-thymocyte globulinSurgeryTransplantationGraft-versus-host diseaseMethotrexateOncologyHematologic NeoplasmsCyclosporineRegression AnalysisDrug Therapy CombinationFemaleTransplantation ConditioningbusinessImmunosuppressive Agentsmedicine.drugThe Lancet. Oncology
researchProduct

Prediction of symptom remission in schizophrenia during inpatient treatment

2007

Standardized consensus criteria for remission in schizophrenia were recently proposed. The present study applied the symptom-severity component of these criteria to a sample of inpatients in order to determine the rates of remission during inpatient treatment and to explore predictors of remission.A total of 288 inpatients from a multi-centre follow-up programme who fulfilled ICD-10 criteria for schizophrenia were included in the present analyses. PANSS ratings at admission and at discharge from hospitalization were used to examine remission status. Clinical and sociodemographic variables at admission were tested for their ability to predict remission at discharge.In total, 55% of the sampl…

AdultMalemedicine.medical_specialtyTreatment outcomeConsensus criteriaLogistic regressionYoung Adult03 medical and health sciences0302 clinical medicineInternational Classification of DiseasesGermanyInternal medicineInterview PsychologicalmedicineHumansYoung adultPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesModels StatisticalFollow up studiesMiddle AgedPrognosismedicine.disease030227 psychiatryHospitalizationPsychiatry and Mental healthTreatment OutcomeROC CurveMulticenter studySchizophreniaPsychiatric status rating scalesSchizophreniaFemaleSchizophrenic PsychologyPsychology030217 neurology & neurosurgeryFollow-Up StudiesThe World Journal of Biological Psychiatry
researchProduct

Neurological diseases and COVID-19: prospective analyses using the UK Biobank

2021

COVID-19 (Coronavirus disease-19) may present with neurological signs, but whether people already affected by neurological conditions are at a higher risk of contracting COVID-19 is still not known. We, therefore, aimed to investigate the association of previously diagnosed neurological conditions with COVID-19. 502,536 community-dwelling UK Biobank participants (54.4% male, mean age 56.6 ± 10.3 years) were included. Among these, 57,463 participants had a diagnosis of neurological conditions (11.43%) and a total of 1326 COVID-19-positive cases were identified (0.26%). Neurological conditions were identified through medical history and linkage to data on hospital admissions (ICD-10 code G00–…

AdultMalemedicine.medical_specialtyUK BiobankNeurologyMovement disordersPopulationLogistic regressionCOVID-19 · Neurological conditions · UK Biobank.Cerebral palsy03 medical and health sciences0302 clinical medicineInternal medicineMedicineHumansMedical history030212 general & internal medicineProspective StudiesProspective cohort studyeducationAgedBiological Specimen Bankseducation.field_of_studybusiness.industryCOVID-19General MedicineOdds ratioMiddle Agedmedicine.diseaseUnited KingdomNeurological conditionsOriginal ArticleFemaleNeurology (clinical)medicine.symptomNervous System Diseasesbusiness030217 neurology & neurosurgery
researchProduct

Development, validation, and initial results of the Angioedema Activity Score

2013

Background Recurrent angioedema (RecA) is a frequent clinical problem characterized by suddenly occurring cutaneous and/or mucosal swellings. Depending on their location, RecA may be painful, hindering, disfiguring, or even life-threatening. The assessment of disease activity in affected patients is important to guide treatment decisions. Currently, however, there is no standardized and validated outcome measure available to do so. Objective To develop and validate the first specific patient-reported outcome instrument to assess disease activity in RecA patients, the Angioedema Activity Score (AAS). Methods After a set of potential AAS items was developed, item evaluation and reduction were…

AdultMalemedicine.medical_specialtyValidation studyAdolescentImmunologyValiditySeverity of Illness IndexYoung AdultRisk FactorsInternal consistencyHumansImmunology and AllergyMedicineAngioedemaReliability (statistics)AgedFace validityAged 80 and overAngioedemabusiness.industryReproducibility of ResultsRegression analysisMiddle AgedConvergent validityPhysical therapyFemalemedicine.symptombusinessAllergy
researchProduct

Predictors of Re‐bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic S…

2018

Abstract Background Transjugular intrahepatic portosystemic shunt (TIPS) has proven clinical efcacy as rescue therapy for cirrhotic patients with acute portal hypertensive bleeding who fail endoscopic treatment. Aims To investigate predictive factors of 6-week and 1-year mortality in patients undergoing salvage TIPS for refractory portal hypertensive bleeding. Methods A total of 144 consecutive patients were retrospectively evaluated. Three logistic regression multivariate models were estimated to individualize prognostic factors for 6-week and 12-month mortality. Log-rank test was used to evaluate survival according to Child–Pugh classes and Bureau’s criteria. Results Mean age 51±10 years,…

AdultMalemedicine.medical_specialtyVariceal bleedingPhysiologymedicine.medical_treatmentPortal venous pressureEsophageal and Gastric VaricesLogistic regressionlaw.inventionCohort Studies03 medical and health sciences0302 clinical medicineRefractoryPredictive Value of TestsRecurrencelawInternal medicinemedicineHumansProspective StudiesMortalityRetrospective StudiesSalvage Therapybusiness.industryGastroenterologyMiddle AgedHepatologyIntensive care unitSurgeryRe bleeding030220 oncology & carcinogenesisTIPSFemale030211 gastroenterology & hepatologyPortasystemic Shunt Transjugular IntrahepaticGastrointestinal HemorrhagebusinessTransjugular intrahepatic portosystemic shunt
researchProduct

Microalbuminuria and early endothelial activation in essential hypertension

2006

We hypothesized that in essential hypertensive patients (EHs), plasma levels of pro-atherogenic adhesion molecules would be increased and related with urine albumin excretion (UAE). Thus, this study was aimed at evaluating biochemical markers of endothelial activation and their relationship with UAE in a group of patients with uncomplicated EH. In basal condition soluble forms of adhesion molecules intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1, as well as 24-h UAE were assayed. One hundred patients with essential hypertension and no diabetes or ultrasonographic evidence of atherosclerosis were included in the study. Seventy normotensive healthy subjec…

AdultMalemedicine.medical_specialtyVascular Cell Adhesion Molecule-1Essential hypertensionEndothelial activationInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansEndothelial dysfunctionProteinuriabusiness.industryCell adhesion moleculeMiddle AgedAtherosclerosisIntercellular Adhesion Molecule-1Intercellular adhesion moleculemedicine.diseaseC-Reactive ProteinEndocrinologyHypertensionMicroalbuminuria hypertension.Regression AnalysisFemaleMicroalbuminuriaEndothelium Vascularmedicine.symptombusinessJournal of Human Hypertension
researchProduct

Combined effects of increasing maternal age and nulliparity on hypertensive disorders of pregnancy and small for gestational age

2019

The mean age of women delivering for the first time is increasing, and this combination could lead to an increased risk of perinatal complications.The objective was to evaluate the potential combined effects of nulliparity and increasing maternal age on small for gestational age (SGA  10th percentile) and hypertensive disorders of pregnancy (HDP).A population-based cohort study was conducted using data routinely collected on all births in 11 hospitals in the Burgundy perinatal network between 2007 and 2016. Pregnant women with singleton deliveries aged 20 years or older were included at delivery and divided into groups according to maternal age (20 to 24-year-old group as a reference). Mult…

AdultMalemedicine.medical_specialty[SDV]Life Sciences [q-bio]PopulationLogistic regressionCohort StudiesYoung Adult03 medical and health sciences0302 clinical medicinePregnancyRisk FactorsInternal MedicinemedicineHumans030212 general & internal medicineRisk factoreducation2. Zero hungereducation.field_of_studyPregnancy030219 obstetrics & reproductive medicinebusiness.industryObstetricsAge FactorsInfant NewbornObstetrics and GynecologyHypertension Pregnancy-InducedMiddle Agedmedicine.disease3. Good health[SDV] Life Sciences [q-bio]ParityLogistic ModelsInfant Small for Gestational AgeSmall for gestational ageFemaleFrancebusinessParity (mathematics)Body mass indexMaternal AgeCohort studyPregnancy Hypertension
researchProduct

Two-dimensional echocardiographic evaluation of left ventricular ejection fraction by the ellipsoid single-plane algorithm: a reliable method for ass…

1995

The reliability of two-dimensional (2D) echocardiographic estimation of left ventricular ejection fraction (EF) is commonly recognized, but no satisfactory data are available about the accuracy of low or very low EF values determined by 2D echocardiography (ECHO-EF). The purpose of our study was to assess the reliability of low ECHO-EF values obtained using a simple time-economical algorithm such as the ellipsoid single-plane area-length method. Radionuclide angiography (RAD-EF) was taken as the standard of comparison. We studied 59 consecutive patients (31 women and 28 men) referred to our echocardiographic laboratory. Both 2D echocardiography and radionuclide angiography were blindly perf…

AdultMalemedicine.medical_specialtyanimal structuresSettore MED/09 - Medicina InternaCardiac Output LowVentricular Function LeftVentricular Dysfunction LeftRadionuclide angiographyVentricule gaucheReference ValuesInternal medicinemedicineHumansPharmacology (medical)AgedEjection fractionmedicine.diagnostic_testPlane (geometry)business.industryTwo dimensional echocardiographyReproducibility of ResultsGated Blood-Pool ImagingSignal Processing Computer-AssistedStroke VolumeMiddle AgedEllipsoidSettore MED/11 - Malattie Dell'Apparato CardiovascolareArea length methodTwo dimensional echocardiography Area-lenght method Radionuclide angiography Ejection fraction Regression analysisEchocardiographyCardiologyFemaleCardiology and Cardiovascular MedicinebusinessNuclear medicineAlgorithms
researchProduct

Development and validation of the Migraine Screen Questionnaire (MS-Q).

2005

Aim.—To develop and evaluate the clinimetric properties of a new migraine screening questionnaire: the Migraine Screen Questionnaire (MS-Q). Background.—Migraine is a public health problem requiring screening programs and tools to ensure early detection. Methods.—A questionnaire was developed based on the criteria of the International Headache Society (IHS) and a review of the literature by a committee of experts. Stage I: The original version of the MS-Q was distributed by mail and completed by Pfizer employees and self-administered to neurological patients; all subjects were afterward evaluated by a neurologist who was blinded to the MS-Q results, to establish an independent IHS diagnosis…

AdultMalemedicine.medical_specialtybusiness.industryNauseaMigraine DisordersValidityReproducibility of ResultsNeurological disordermedicine.diseaseLogistic regressionConfidence intervalClinical trialLogistic ModelsNeurologyMigraineCronbach's alphaSurveys and QuestionnairesPhysical therapyMedicineHumansFemaleNeurology (clinical)medicine.symptombusinessHeadache
researchProduct